IMA · ImageneBio, Inc.
$5.51
-0.10 (-1.78%)
At close · Aug 21
Market Cap
$62.55M
Shares
11.35M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Kristin Yarema | Chief Executive Officer | $8,171,198 |
| Mark Manfredi | Former President and Chief Executive Officer | $2,711,817 |
| Jotin Marango | M.D., Ph.D. Former Chief Financial Officer | $1,569,237 |
| YuFang Lu | M.D., Ph.D. Former Chief Medical Officer | $647,852 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Jotin Marango | M.D., Ph.D. Former Chief Financial Officer | $1,511,194 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Yanina Grant-Huerta | Chief Financial Officer, principal financial officer and principal accounting officer | Appointed | 2026-07-23 |
| Robert Lally | Senior Vice President of Finance and Operations and principal accounting officer | Resigned | 2026-06-26 |
| Joseph P. Slattery | Class II director | Appointed | 2026-06-17 |
| David P. Bonita, M.D. | Class II director | Appointed | 2026-06-17 |
| Bob Lally | Principal Accounting Officer | Appointed | 2026-03-17 |
| Steven Hui Wang | member of the Board of Directors | Resigned | 2026-02-17 |
| Yufang Lu, M.D., Ph.D. | Chief Medical Officer | Resigned | 2025-12-18 |
| Joseph P. Slattery | Director | Appointed | 2025-11-05 |
| Kristin Yarema, Ph.D. | interim principal financial officer | Appointed | 2025-10-22 |
| Jotin Marango, M.D., Ph.D. | Chief Financial Officer and principal financial officer | Resigned | 2025-10-10 |
| Jonathan Jian Wang, Ph.D., MBA | Chair of the Board | Appointed | 2025-07-29 |
| Kristin Yarema, Ph.D. | Director | Appointed | 2025-07-29 |
| Weiguo Su, Ph.D. | Director | Appointed | 2025-07-29 |
| Stephen Hui Wang, MBA | Director | Appointed | 2025-07-29 |
| Jonathan Jian Wang, Ph.D., MBA | Director | Appointed | 2025-07-29 |
| Jonathan Jian Wang, Ph.D. | Inmagene's President and Chief Executive Officer | Terminated | 2025-07-29 |
| Owen Hughes | Director | Resigned | 2025-07-29 |
| Richard Wooster, Ph.D. | Director | Resigned | 2025-07-29 |
| Mark Manfredi, Ph.D. | Director | Resigned | 2025-07-29 |
| Maria Koehler, M.D., Ph.D. | Director | Resigned | 2025-07-29 |
| Jean-François Formela, M.D. | Director | Resigned | 2025-07-29 |
| Iain Dukes, D.Phil. | Director | Resigned | 2025-07-29 |
| Erin Butler | Senior Vice President, Finance and Administration (Principal Accounting Officer) | Appointed | 2025-07-29 |
| Yufang Lu, M.D., Ph.D. | Chief Medical Officer | Appointed | 2025-07-29 |
| Jotin Marango, M.D., Ph.D. | Chief Financial Officer (Principal Financial Officer) and Corporate Secretary | Appointed | 2025-07-29 |
Key facts
CIK
1835579
CUSIP
45175G207
13F (30d)
36 filings
36 filers
Visit website
Investor relations